Advanced Therapies Manufacturing Capacity in North America

Phacilitate
2 November 2020
SHARE NOW

A comprehensive guide showcasing the growing cell and gene therapy and viral vector manufacturing landscape in North America

Welcome to the 2020 edition of Phacilitate’s ‘Manufacturing Advanced Therapies in North America’ map; a visual guide of service providers covering your needs for advanced cell and gene therapy manufacturing. Whether you need a vector made or need a place for your clinical trial patient product to be produced, let us guide you through some of the region’s leading providers. This map contains a range of qualified companies that have been servicing the cell and gene therapy space for decades.

View the map here

We all have faced that moment when your clinical design is coming into focus and suddenly you realise that getting your vector made on time or finding enough capacity to manufacture your therapy is proving to be more challenging then you expected. Listed on this map are fully GMP compliant, experienced organisations with a host of information about capacity, quality systems, specialist services and, of course, contact details for you to start that all-important conversation. Here’s an overview of some of the 18 companies featured:

If your needs are for vector manufacturing check out: 

  • Aldevron
  • VGXI
  • Waisman Biomanufacturing
  • Vigene Biosciences
  • Cognate Bioservices
  • Catalent Cell & Gene Therapy

If you are looking into non-viral gene-modified therapies or need GMP proteins take a look at: 

  • Bio-Techne

For services related to clinical trial patient processing: 

  • CCRM
  • Minaris Regenerative Medicine
  • Bio-Techne
  • Cognate Bioservices
  • Lonza
  • KBI Biopharma
  • WuXi Advanced Therapies

 For other cell and gene therapy GMP manufacturing providers see what is available at:  

  • MilliporeSigma
  • C3i
  • Waisman Biomanufacturing
  • FUJIFILM Diosynth Biotechnologies

These companies have been able to maintain their operations during these difficult times of Covid-19. They have put into place additional safety mechanisms to ensure the utmost safety in processing your cells and/or manufacturing your vectors.

Kindest regards and stay safe,

Jeff Liter, Sr. Advisor

Bio-Techne

 

Have you seen the Europe edition?